{
  "id": "1473447b96f71212",
  "title": "FDA Accepts Application for Novel R / R Primary CNS Lymphoma Treatment",
  "description": "20260219T164500Z",
  "content": "",
  "source": "cancertherapyadvisor.com",
  "source_url": "https://www.cancertherapyadvisor.com/news/fda-accepts-application-for-novel-r-r-primary-cns-lymphoma-treatment/",
  "published_at": "20260219T164500Z",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.cancertherapyadvisor.com/news/fda-accepts-application-for-novel-r-r-primary-cns-lymphoma-treatment/",
    "url_mobile": "",
    "title": "FDA Accepts Application for Novel R / R Primary CNS Lymphoma Treatment",
    "seendate": "20260219T164500Z",
    "socialimage": "https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2024/01/CTA_1200x675.png",
    "domain": "cancertherapyadvisor.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}